This analysis examines Elsevier's claims about separation of open access revenue from subscriptions, suggesting potential revenue concerns.
For an open-access advocate, it's easy to pick on Elsevier. An enormous and immensely profitable publisher, it has been, in my personal view, obstructive towards the implementation of open access. Again, in my opinion, this seems to be because it fears for its revenue stream, rather than because it cares about science. The ElsevierValentines hashtag was puerile, but fun, and demonstrated this sentiment. But these are just my opinions.
No takes yet. Share an insight, caveat, or question.
Martin Paul Eve (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: